List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 3323 studies with search of:   United Kingdom
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Natalizumab
2 Completed Study of OSI-211 Vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: OSI-211 (Liposomal Lurtotecan)
3 Completed Safety Study of Apixaban in Recent Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Interventions: Drug: Apixaban;   Drug: Apixaban;   Drug: Placebo
4 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
5 Completed Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: UK-432,097;   Drug: Placebo
6 Completed A Double-Blind "Preferred" Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Drug: Levitra (Vardenafil, BAY38-9456);   Drug: Placebo
7 Recruiting Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: tiotropium respimat;   Drug: placebo
8 Completed Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Conditions: Breast Cancer;   Metastases
Interventions: Drug: Ixabepilone + Capecitabine;   Drug: Capecitabine
9 Active, not recruiting Study of NY-ESO-1 ISCOMATRIX® in Patients With High-Risk, Resected Melanoma
Condition: Melanoma
Interventions: Biological: NY-ESO-1 ISCOMATRIX®;   Biological: ISCOMATRIX® adjuvant
10 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
11 Completed Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
Condition: NSCLC
Intervention: Drug: Gefitinib
12 Active, not recruiting Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety
Condition: Diabetes Mellitus
Interventions: Drug: Randomization to Exubera (insulin human [rDNA origin] inhalation powder) or Usual Diabetes Care;   Drug: Randomization to Exubera (insulin human [rDNA origin] inhalation powder) or Usual Diabetes Care
13 Recruiting Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Condition: Cushing's Syndrome
Intervention: Drug: Mifepristone
14 Terminated A Comparison of Two Daily Disposable Contact Lenses
Conditions: Refractive Error;   Myopia
Interventions: Device: nelfilcon A;   Device: narafilcon A
15 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
16 Completed Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer
Conditions: Gastroesophageal Adenocarcinoma;   Gastric Adenocarcinoma
Intervention: Drug: OSI-7904L
17 Completed To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
Condition: Alzheimer's Disease
Intervention: Drug: Atorvastatin
18 Completed Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke
Condition: Cardiovascular Disease
Intervention: Drug: atorvastatin
19 Active, not recruiting Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
Condition: EGFR-Expressing Metastatic Colorectal Cancer
Interventions: Drug: Cetuximab, 5-Fluorouracil, Folinic acid, Irinotecan;   Drug: 5-Fluorouracil, Folinic acid, Irinotecan
20 Recruiting Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Conditions: Osteoarthritis;   Arthritis, Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Diclofenac + Omeprazole

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options